CENTER FOR MEDICARE ADVOCACY INC MEDICARE PART D

  • Slides: 11
Download presentation
CENTER FOR MEDICARE ADVOCACY, INC. MEDICARE PART D: The Impact on Dual Eligible Beneficiaries

CENTER FOR MEDICARE ADVOCACY, INC. MEDICARE PART D: The Impact on Dual Eligible Beneficiaries Vicki Gottlich, Esq. March 2006 www. medicareadvocacy. org

PART D ISSUES FOR PEOPLE WITH MEDICARE & MEDICAID § Problems caused by random

PART D ISSUES FOR PEOPLE WITH MEDICARE & MEDICAID § Problems caused by random assignment to low-income Part D plans. § Difficulties in accessing medically necessary drugs. § Inability to meet minimal cost sharing requirements. www. medicareadvocacy. org Copyright © Center for Medicare Advocacy, Inc. 2

RANDOM ASSIGNMENT TO PART D PLANS Random assignment results in unequal access caused by

RANDOM ASSIGNMENT TO PART D PLANS Random assignment results in unequal access caused by variations in coverage of drugs. § OIG Report: • • 1/3 of duals assigned to plans covering less than 85% of 178 most common Part D drugs. Only 18% assigned to plans covering all 178 drugs. § Avalere Health Issue Brief: • • Many California duals have worse coverage than under Medi-Cal (Medicaid). Number of drugs on formularies varies from 530 -3360. www. medicareadvocacy. org Copyright © Center for Medicare Advocacy, Inc. 3

RANDOM ASSIGNMENT TO PART D PLANS Potential gaps in coverage for duals § Issues

RANDOM ASSIGNMENT TO PART D PLANS Potential gaps in coverage for duals § Issues for duals who change plans: • Between 6 and 18 low-income plans. • Difficulties in determining which plan is “best”. • Communication issues may delay enrollment in new plans. § New duals may lose all drug coverage • • Lose Medicaid when become Medicare eligible. Will they be enrolled in a Part D plan in time? www. medicareadvocacy. org Copyright © Center for Medicare Advocacy, Inc. 4

ACCESS TO MEDICALLY NECESSARY DRUGS § Transitions process issue: • Plans not providing 30

ACCESS TO MEDICALLY NECESSARY DRUGS § Transitions process issue: • Plans not providing 30 day “first fills” for non • • formulary drugs. CMS’s extension of transition process from 30 to 90 days is voluntary. Enrollees not informed to either get a new prescription or to seek an exception before transition period ends on March 31, 2006. www. medicareadvocacy. org Copyright © Center for Medicare Advocacy, Inc. 5

ACCESS TO MEDICALLY NECESSASRY DRUGS § Exceptions and appeals processes: • • Vary from

ACCESS TO MEDICALLY NECESSASRY DRUGS § Exceptions and appeals processes: • • Vary from plan to plan. Exceptions require participation by doctors. • Some doctors charging fees to fill out forms. • • Enrollees may not have sufficient information to pursue appeals. No supply of drugs pending appeal for most duals. § Barriers to switching to formulary drugs • Issues in getting doctors’ appointments. www. medicareadvocacy. org Copyright © Center for Medicare Advocacy, Inc. 6

INABILITY TO MEET COST SHARING REQUIREMENTS § Duals pay co-payments of $0 -$5/drug depending

INABILITY TO MEET COST SHARING REQUIREMENTS § Duals pay co-payments of $0 -$5/drug depending on income level, residence. • • • Cost sharing obligations new for some duals. Cost sharing could be waived under Medicaid but not under Medicare. Cost sharing amounts to be indexed yearly. § Medicaid does not wrap around Part D benefit. • • Unlike for other Medicare services, Medicaid doesn’t pick up cost sharing. States vary in Medicaid coverage for Part D excluded drugs. www. medicareadvocacy. org Copyright © Center for Medicare Advocacy, Inc. 7

INABILITY TO MEET COST SHARING REQUIREMENTS § Institutionalized duals have no cost sharing. §

INABILITY TO MEET COST SHARING REQUIREMENTS § Institutionalized duals have no cost sharing. § Duals who live in assisted living, board & care facilities are not institutionalized. • Pay all but small amount of their income to • facility for care. Must pay co-payments – costs often exceed personal needs allowance. www. medicareadvocacy. org Copyright © Center for Medicare Advocacy, Inc. 8

RECOMMENDATIONS § Increase funding to organizations that assist individual beneficiaries. § Assign duals to

RECOMMENDATIONS § Increase funding to organizations that assist individual beneficiaries. § Assign duals to plans whose formularies match their needs- “intelligent random assignment. ” § Simplify Part D by standardizing • • • benefit packages transition policies exceptions and appeals processes. www. medicareadvocacy. org Copyright © Center for Medicare Advocacy, Inc. 9

RECOMMENDATIONS § Eliminate cost-sharing for all duals receiving long-term care services, regardless of setting.

RECOMMENDATIONS § Eliminate cost-sharing for all duals receiving long-term care services, regardless of setting. § Allow Medicaid to “wrap around” Part D. § Ensure seamless transition from Medicaid to Medicare drug coverage. § Add a drug benefit to traditional Medicare. www. medicareadvocacy. org Copyright © Center for Medicare Advocacy, Inc. 10

CENTER FOR MEDICARE ADVOCACY, INC. MEDICARE PART D: The Impact on Dual Eligible Beneficiaries

CENTER FOR MEDICARE ADVOCACY, INC. MEDICARE PART D: The Impact on Dual Eligible Beneficiaries For continually updated information go to www. medicareadvocacy. org

Day 2 Medicare Advantage Part C Review MedicareDay 2 Medicare Advantage Part C Review Medicare
Medicare Basics The Parts of Medicare 2 PartMedicare Basics The Parts of Medicare 2 Part
Medicare Part D and Medicare Advantage October 2020Medicare Part D and Medicare Advantage October 2020
Medicare Prescription Drug Program Part D Review MedicareMedicare Prescription Drug Program Part D Review Medicare
California Medicare Coalition Medicare and Part D WhoCalifornia Medicare Coalition Medicare and Part D Who
Medicare HIT Policies Medicare and Part D eMedicare HIT Policies Medicare and Part D e
Special Education Advocacy AHRC Advocacy Services January 15Special Education Advocacy AHRC Advocacy Services January 15
Empowerment Advocacy SelfDetermination SPCD 524 Advocacy SelfAdvocacy EmpowermentEmpowerment Advocacy SelfDetermination SPCD 524 Advocacy SelfAdvocacy Empowerment
Interpreting Advocacy Issues Global Advocacy Education Team MinistriesInterpreting Advocacy Issues Global Advocacy Education Team Ministries
Queensland Advocacy Incorporated Systems and Legal Advocacy forQueensland Advocacy Incorporated Systems and Legal Advocacy for
ADVOCACY CAMPAIGNS Advocacy Research Coalition Building and NegotiationADVOCACY CAMPAIGNS Advocacy Research Coalition Building and Negotiation
Advocacy Lee Ann Kendrick Regional Advocacy Specialist OctoberAdvocacy Lee Ann Kendrick Regional Advocacy Specialist October
NGO Advocacy Work Czech NGOs Advocacy experience PetrNGO Advocacy Work Czech NGOs Advocacy experience Petr
Advocacy 101 How Advocacy Can Help End HomelessnessAdvocacy 101 How Advocacy Can Help End Homelessness
Advocacy 102 TOPICS Advocacy 101 Quick Review WhyAdvocacy 102 TOPICS Advocacy 101 Quick Review Why
Community Reading Advocacy Brian Cambra Community Reading AdvocacyCommunity Reading Advocacy Brian Cambra Community Reading Advocacy
Student Advocacy Child Advocacy Definition To promote theStudent Advocacy Child Advocacy Definition To promote the
Responsible Advocacy Doing good right Advocacy Speaking upResponsible Advocacy Doing good right Advocacy Speaking up
Arts Advocacy Presentation Checklist for the Arts AdvocacyArts Advocacy Presentation Checklist for the Arts Advocacy
AHF Advocacy AGENDA INTRODUCTIONS ADVOCACY Definition Strategies AHFAHF Advocacy AGENDA INTRODUCTIONS ADVOCACY Definition Strategies AHF
Collaboration and Advocacy techniques Advocacy Screen 1 ofCollaboration and Advocacy techniques Advocacy Screen 1 of
What is Advocacy Advocacy is ResultBased Communication WhoWhat is Advocacy Advocacy is ResultBased Communication Who
NETWORKING AND ADVOCACY Advocacy Campaigns for Childs RightsNETWORKING AND ADVOCACY Advocacy Campaigns for Childs Rights
Queensland Advocacy Incorporated Systems and Legal Advocacy forQueensland Advocacy Incorporated Systems and Legal Advocacy for
Positive Proactive Advocacy Ideas NOW Positive Pro AdvocacyPositive Proactive Advocacy Ideas NOW Positive Pro Advocacy
What is Advocacy Advocacy is ResultBased Communication WhoWhat is Advocacy Advocacy is ResultBased Communication Who
Advocacy Survey Trial Advocacy What It Means StagesAdvocacy Survey Trial Advocacy What It Means Stages
LOBBYING AND ADVOCACY FOR NONPROFITS WHAT IS ADVOCACYLOBBYING AND ADVOCACY FOR NONPROFITS WHAT IS ADVOCACY
Advocacy Rewind 2013 Advocacy Milestones 2013 JAN EWBAdvocacy Rewind 2013 Advocacy Milestones 2013 JAN EWB
Advocacy and Legal Advice Centre program Advocacy andAdvocacy and Legal Advice Centre program Advocacy and
CUSTOMERFOCUSED SERVICES ADVOCACY SERVICES COMPLAINT RESOLUTION ADVOCACY SERVICESCUSTOMERFOCUSED SERVICES ADVOCACY SERVICES COMPLAINT RESOLUTION ADVOCACY SERVICES
Advocacy What is Advocacy For our purposes actingAdvocacy What is Advocacy For our purposes acting
Advocacy Influencing Leaders Michael Kropac seecon international AdvocacyAdvocacy Influencing Leaders Michael Kropac seecon international Advocacy
Advocacy Self Advocacy Welcome Darrilyn Mc Crerey DirectorAdvocacy Self Advocacy Welcome Darrilyn Mc Crerey Director